| Jangka wektu | Prediksi rega | kepungkur | Sajarah | Wawasan |
|---|---|---|---|---|
| sesuk | $0.9587 ▲ +1.15% | wingi | $0.9432 ▼ -0.48% | Sesuk Rani Therapeutics Holdings Inc. Class A Common Stock (RANI) persiyapan wis anchored kanggo $0.9478 lan target $0.9587 (+1.15%). Waca sing cedhak yaiku munggah; nonton $0.9762 / $0.9194 amarga volatilitas sing diwujudake saben dina babagan 5.93%. |
Sesuk Rani Therapeutics Holdings Inc. Class A Common Stock (RANI) persiyapan wis anchored kanggo $0.9478 lan target $0.9587 (+1.15%). Waca sing cedhak yaiku munggah; nonton $0.9762 / $0.9194 amarga volatilitas sing diwujudake saben dina babagan 5.93%. | ||||
| Minggu | $0.9817 ▲ +3.58% | Minggu kepungkur | $0.9336 ▼ -1.50% | Model 7 dina Rani Therapeutics Holdings Inc. Class A Common Stock pindhah saka $0.9336 menyang $0.9817 (+3.58%). Iku menehi konteks momentum munggah kanggo saham iki, supaya break watara $0.9762 / $0.9194 prakara luwih saka siji obah. |
Model 7 dina Rani Therapeutics Holdings Inc. Class A Common Stock pindhah saka $0.9336 menyang $0.9817 (+3.58%). Iku menehi konteks momentum munggah kanggo saham iki, supaya break watara $0.9762 / $0.9194 prakara luwih saka siji obah. | ||||
| wulan | $1.02 ▲ +7.61% | Wulan kepungkur | $0.9175 ▼ -3.20% | Target 1 wulan Rani Therapeutics Holdings Inc. Class A Common Stock yaiku $1.02 (+7.61%), dibandhingake karo referensi langsung ing cedhak $0.9478. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. |
Target 1 wulan Rani Therapeutics Holdings Inc. Class A Common Stock yaiku $1.02 (+7.61%), dibandhingake karo referensi langsung ing cedhak $0.9478. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. | ||||
| taun | $1.08 ▲ +13.67% | Taun kepungkur | $0.8934 ▼ -5.74% | Skenario 1 taun Rani Therapeutics Holdings Inc. Class A Common Stock nuduhake $1.08 (+13.67%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. |
Skenario 1 taun Rani Therapeutics Holdings Inc. Class A Common Stock nuduhake $1.08 (+13.67%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. | ||||
| 5 Taun | $1.21 ▲ +27.86% | 5 Taun kepungkur | $0.8369 ▼ -11.70% | Tampilan 5 taun Rani Therapeutics Holdings Inc. Class A Common Stock yaiku $1.21 (+27.86%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. |
Tampilan 5 taun Rani Therapeutics Holdings Inc. Class A Common Stock yaiku $1.21 (+27.86%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. | ||||
| Indikator | Nilai | Sinyal |
|---|---|---|
| regane | $0.9478 | agêng |
| Ganti saben dina | -2.66% | Ngisor |
| Volatilitas Kab | 20.0% | agêng |
| kapercayan | 63% | Ndhuwur |
| Sumber Data | nasdaq-screener | agêng |
| saiki | $0.9478 | Ganti saben dina | -2.66% |
| Pasar Kab | $117.24M | Sumber | nasdaq-screener |
Gagasan sing gegandhengan kanggo navigasi internal, diklompokaké miturut persiyapan sisih ndhuwur sing luwih kuwat lan kurang lemah ing pasar sing padha.